Regular use of laxatives linked to risk for all-cause dementia
Feb 23, 2023
Risk for all-cause, vascular dementia was increased with number of regularly used laxative types
Instrumental activities of daily living test could ID Alzheimer’s disease
Jun 28, 2023
An association was found between simulated real-life IADL and interactions of amyloid and early tau accumulation in cognitively normal seniors.
One-year mortality 13.4 percent for seniors after major surgery
Oct 25, 2022
THe one-year mortality following major surgery increased for adults aged 65 years or older with frailty or probable dementia.
Resident falls account for 75 percent of insurance claims with payment in senior living
By
Kimberly Bonvissuto
Mar 06, 2023
Resident falls claims continue to be the primary insurance loss driver for senior living providers, according to a new report.
More news for Friday, March 1
By
Kimberly Bonvissuto
Mar 01, 2024
What states spent on dementia care in 2010 through 2019 … Impaired sense of direction may be early sign of Alzheimer’s … Experiencing low healthcare quality is associated with greater dementia risk...
Neurological conditions ranked as leading cause of disability-adjusted life years globally
Mar 15, 2024
Between 1990 and 2021, there was an 18.2 percent increase in the global DALY counts attributed to those conditions
Lower cutoff points for Montreal cognitive assessment needed
Jan 17, 2024
A high false-positive rate was seen when used in primary care with a diverse patient population.
Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
May 17, 2023
Genetically determined high-density lipoprotein cholesterol and systolic blood pressure were linked to increased odds of Alzheimer’s disease.
Pioglitazone use linked to reduced dementia risk in T2DM
Feb 16, 2023
The reduction in risk was greatest for those with a history of ischemic heart disease or stroke.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.